More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Release of its First-Ever CBD Gel Capsules

Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Release of its First-Ever CBD Gel Capsules

by adminAdrianRamirez | Aug 30, 2018 | Dixie Botanicals, Press Releases

SAN DIEGO, Aug. 30, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary Dixie Botanicals® has released new cannabidiol (CBD) gel capsules, the first of their...
Pro Baseball Hall of Famer Joins Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team

Pro Baseball Hall of Famer Joins Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team

by adminAdrianRamirez | Aug 29, 2018 | Kannaway, Press Releases

Former Major League Pitcher Goose Gossage to Spread Awareness on Benefits of CBD SAN DIEGO, Aug. 28, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that former New York Yankees and...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Event on the Benefits of CBD with Former Resident Doctors of Neurology in Belo Horizonte, Brazil

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Event on the Benefits of CBD with Former Resident Doctors of Neurology in Belo Horizonte, Brazil

by adminAdrianRamirez | Aug 23, 2018 | HempMeds Brasil, Press Releases

SAN DIEGO, Aug. 23, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil will host the Third Meeting of Former Residents of Neurology at John Paul II...
Medical Marijuana, Inc. Announces Q2 2018 as the Largest Sales Revenue Quarter in Company History

Medical Marijuana, Inc. Announces Q2 2018 as the Largest Sales Revenue Quarter in Company History

by adminAdrianRamirez | Aug 21, 2018 | HempMeds, Kannaway, Press Releases

SAN DIEGO, Aug. 21, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the company and its subsidiaries Kannaway®, HempMeds®, HempMeds® Mexico and HempMeds® Brasil have booked...
Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Tour

Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Tour

by adminAdrianRamirez | Aug 17, 2018 | Kannaway, Press Releases

SAN DIEGO, Aug. 17, 2018 — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary Kannaway® will host a European tour during the month of August. This tour will host events in six cities to provide Kannaway® brand ambassadors with the chance to...
Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes New Brand Ambassadors to Achieve National Director Elite Rank

Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes New Brand Ambassadors to Achieve National Director Elite Rank

by adminAdrianRamirez | Aug 16, 2018 | Kannaway, Press Releases

SAN DIEGO, Aug. 16, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Kannaway®, the first hemp lifestyle network to offer phyto-cannabinoid botanical products, is...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.